$12M capital infusion pumps Prairie Village-based Artio Medical to $46M in funding
April 29, 2021 | Startland News Staff
A Johnson County medical device company announced Thursday the closing of an additional $12 million tranche of Series A financing — advancing the startup’s tech toward clinical study and commercialization with the backing of a leading Kansas City real estate developer.
“We are thrilled to close this round of financing with strong support from existing investors who share our mission to provide better patient outcomes,” said Dr. F. Nicholas Franano, president and CEO of Artio. “The Artio team is focused on the road ahead as we advance multiple development programs and prepare for commercialization of our first product.”
The funding brings Artio’s total capital raised to $46 million, Franano said.
Click here to see why Artio Medical, formerly also known as Metactive, was named one of Startland News’ Kansas City Startups to Watch in 2019.
Led by existing investors Sarah Hagedorn and Nathaniel Hagedorn — founder and CEO of Northpoint Development — the deal announced Thursday will be used to accelerate the development of Artio’s peripheral vascular product pipeline, which is highly complementary with significant overlap in call points and procedures, the company said.
The Amplifi Vein Dilation System, which aims to prepare hemodialysis patients for successful vascular access site creation, has shown promising results in initial clinical testing, Artio said in a press release. And the Solus Gold Embolization Device comprises a low-profile, flexible catheter assembly and a non-porous, gold balloon-like implant and is designed for precise placement and immediate vessel occlusion. The device has shown exceptional performance in preclinical testing, the company said.
“Nick has built a broad, diverse portfolio of highly innovative products at Artio and is assembling a world-class team to develop and commercialize them,” said Nathaniel Hagedorn. “We were pleased to have the opportunity to lead this round of financing and to invest additional capital to move the company and its mission forward.”
Just over a year ago, Artio announced its rebranding from “Metactive” and a fresh $8.8 million round to help boost its best-in-class products for the peripheral vascular and neurovascular markets.
Click here to learn more about Artio Medical.
Featured Business
2021 Startups to Watch
stats here
Related Posts on Startland News
Meet the leaders driving Black & Veatch’s entrepreneurial revival
In June, Kansas City construction giant Black & Veatch kicked off an effort to accelerate new, innovative ideas by adopting a concept common among startups. The Overland Park-based corporation launched the B&V Growth Accelerator, which hopes to challenge the global firm’s traditional methods of generating and launching ideas. Black & Veatch — which works with…
One Kansas City startup survives national Kauffman contest
After about a month of public deliberation, the 1 in a Million pitch competition has narrowed participating startups down to a top five — and one hails from Kansas City. Although five area companies advanced to the top 40, The Grooming Project is last startup standing from Kansas City. A panel of Kauffman fellows will…
Not in Kansas anymore: Mycroft opens Kansas City, Silicon Valley offices
Editor’s note: This content is sponsored by LaunchKC but independently produced by Startland News. After a recent seed round that was topped off with a $50,000 LaunchKC grant, artificial intelligence startup Mycroft is moving from Lawrence to the City of Fountains. Mycroft — which developed an open-source, artificial intelligence device similar to Amazon Echo — not…
AOL founder Steve Case says innovators must become policy savvy
Get familiar with public policy or your company will get left behind. That was the forward-looking message that AOL founder Steve Case had for a group of about 200 investors and entrepreneurs at the 2016 Kauffman Fellows summit in Kansas City. Now the CEO of Revolution, Case argued that investors, entrepreneurs and policymakers will have…